Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Cyclosporin Treatment Report
What is Cyclosporin?

Cyclosporin is an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It has been studied in transplants of skin, heart, kidney, lung, pancreas, bone marrow and small intestine.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Other 5 0
Dry Eye Syndrome 4 1
Dry, burning eyes 2 0
Sjogrens syndrome 2 0
Inflammation, interior of eye (Pars planitis) 1 1
Pain 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
1 33%
Mild
0 0%
None
2 67%

Most commonly reported side effects

Blurry vision
1 33%
  • Mild
  • Moderate
  • Severe

Dosages

  20ml as needed 0.05 daily 0.05 g daily 0.1 g daily 0.2 g daily 1 daily 250 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Cyclosporin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 20% Did not seem to work: 20%
Side effects too severe
1 20% Side effects too severe: 20%
Course of treatment ended
1 20% Course of treatment ended: 20%

See all 3 patients who’ve stopped taking Cyclosporin

Currently Taking Cyclosporin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
1
0
2
1
3

Stopped Taking Cyclosporin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
0
2

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 33%
Usually
2 67%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
2 67%
Not at all
1 33%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
1 33%
$25-49
0 0%
< $25
0 0%

Report created on November 22, 2009.